Home › Diffuse Scleroderma › Kansas › Kansas City
Diffuse Scleroderma clinical trials in Kansas City, KS
4 studies for Diffuse Scleroderma are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc)
RecruitingPhase 2
- EncompaSSc site in Kansas City, KS, Kansas City
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
RecruitingPhase 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RecruitingPhase 2/3
- University of Kansas Medical Center, Kansas City
Diffuse Scleroderma trials in other cities
- New York City, NY8 studies
- Chicago, IL7 studies
- Ann Arbor, MI7 studies
- Durham, NC6 studies
- Los Angeles, CA6 studies
- Baltimore, MD5 studies
- Houston, TX5 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Pittsburgh, PA4 studies
- New Orleans, LA4 studies
- Charleston, SC3 studies
Other studies in Kansas City
- Interstitial Lung Diseases14 studies
- Cardiovascular Disease14 studies
- Obesity14 studies
- Heart Failure13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Prostate Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia11 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- Parkinson's Disease9 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.